Literature DB >> 35354992

Closing in on a cure for hepatitis B.

Elie Dolgin.   

Abstract

Entities:  

Keywords:  Diseases; Drug discovery; Medical research; Therapeutics

Mesh：

Year:  2022        PMID： 35354992     DOI： 10.1038/d41586-022-00812-1

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   69.504


× No keyword cloud information.
  2 in total

1.  A global scientific strategy to cure hepatitis B.

Authors:  Peter A Revill; Francis V Chisari; Joan M Block; Maura Dandri; Adam J Gehring; Haitao Guo; Jianming Hu; Anna Kramvis; Pietro Lampertico; Harry L A Janssen; Massimo Levrero; Wenhui Li; T Jake Liang; Seng-Gee Lim; Fengmin Lu; M Capucine Penicaud; John E Tavis; Robert Thimme; Fabien Zoulim
Journal:  Lancet Gastroenterol Hepatol       Date:  2019-04-10

2.  Safety, tolerability and antiviral activity of the antisense oligonucleotide bepirovirsen in patients with chronic hepatitis B: a phase 2 randomized controlled trial.

Authors:  Man-Fung Yuen; Jeong Heo; Jeong-Won Jang; Jung-Hwan Yoon; Young-Oh Kweon; Sung-Jae Park; Yvonne Tami; Shihyun You; Phillip Yates; Yu Tao; Jennifer Cremer; Fiona Campbell; Robert Elston; Dickens Theodore; Melanie Paff; C Frank Bennett; T Jesse Kwoh
Journal:  Nat Med       Date:  2021-10-12       Impact factor: 53.440
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.